CCA Industries Inc
Change company Symbol lookup
Select an option...
CAWW CCA Industries Inc
SEDG Solaredge Technologies Inc
TEUFF Box Ships Inc
VZ Verizon Communications Inc
XRTXF XORTX Therapeutics Inc
TINLY Teijin Ltd
RVSDF Riverside Resources Inc
NMRD Nemaura Medical Inc
MLRKF Millrock Resources Inc
CLUB Town Sports International Holdings Inc

Consumer Staples : Personal Products | Small Cap ValueCompany profile

CCA Industries, Inc. (CCA) manufactures and distributes health and beauty aid products. The Company is engaged in the sale of products in several health-and-beauty aids over-the-counter drug and remedies, and cosmeceutical categories. Under its brand names, the Company markets several different but categorically related products. The Company's principal brand and trademark names include Plus+White (oral health-care products), Sudden Change (skin-care products), Nutra Nail (nail treatments), Bikini Zone (pre and after-shave products), Hair Off (depilatories), Solar Sense (sun-care products), Sunset Cafe (perfumes), Lobe Wonder (ear-care product) and Scar Zone (scar diminishing cream).The Company markets its products to drug, food and mass-merchandise retail chains, warehouse clubs and wholesalers, throughout the United States, and through distributors internationally.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Domestic Auto Industry Outlook: Near-Term Prospects Bleak

7:12 am ET August 2, 2019 (Zacks) Print

The Zacks Domestic Auto industry incorporates companies that are engaged in designing, manufacturing and retailing of vehicles across the globe. The vehicles include passenger cars, crossover vehicles, sport utility vehicles (SUVs), trucks, vans, motorcycles and electric vehicles (EVs). Importantly, the industry creates a large number of job opportunities. Also, the industry is at the forefront of innovation, courtesy of its nature as well as the transformation that it is going through. Several companies have engine and transmission plants and conduct research and development (R&D) and testing.

The industry includes prominent names such as General Motors Company (GM) and Ford Motor Company (F), alongside EV pioneer Tesla (TSLA) and motor cycle maker Harley-Davidson (HOG).

Let’s take a look at the industry’s three major themes:

•    The auto sector is undergoing radical changes. There has been a sharp decline in demand for sedans and hatchbacks while demand for crossovers, SUVs and pick-up trucks has skyrocketed. This discernible shift in consumers’ preference has prompted automakers to alter their production strategies in favor of spacious and more comfortable vehicles.

•    The auto industry has witnessed a noticeable increase in mobility and ride-hailing services. As the future of the industry is extremely uncertain, automakers are going all out to enhance the new capabilities and opting for acquisitions.

•    The problem of safety still haunts automakers. In recent times, there have been a large number of recalls. This has not only marred automakers’ image but also put lives under threat.

Zacks Industry Rank Indicates Dim Prospects

The Zacks Domestic Auto industry is a seven-stock group within the broader Zacks Auto sector. The industry currently carries a Zacks Industry Rank #219, which places it in the bottom 14% of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates dull near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.

The industry’s positioning in the bottom 50% of the Zacks-ranked industries is a result of negative earnings outlook for the constituent companies in aggregate. Over the past year, the industry’s earnings estimate for the current year has declined 1.1%.

Before we present a few domestic auto stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Outperforms Sector But Lags S&P 500

The Domestic Auto industry has outperformed its own sector over the past year but underperformed the Zacks S&P 500 composite over the same time frame.

Over this period, the industry has declined 6.8% compared with the sector’s decline of 14.1%. The Zacks S&P 500 composite however has gained 3.9% in the same time frame.

One-Year Price Performance

Industry’s Current Valuation

On the basis of trailing 12-month enterprise value-to EBITDA (EV/EBITDA), which is a commonly used multiple for valuing auto stocks, the industry is currently trading at 12.86X compared with the S&P 500’s 11.46X. It is above the sector’s trailing-12-month EV/EBITDA of 9.19X.

Over the past five years, the industry has traded as high as 16.2X, as low as 6.16X and at a median of 11.25X, as the chart below shows.

Trailing 12-Month Enterprise Value-to EBITDA (EV/EBITDA) Ratio

Trailing 12-Month Enterprise Value-to EBITDA (EV/EBITDA) Ratio

Bottom Line

The near-term prospects of the domestic auto industry do not appear to be much encouraging. The uncertainties surrounding autonomous and electric future and need for rapid adjustments due to shifting demand have added to automakers’ woes.
Currently, none of the stocks in the Zacks Domestic Auto sport a Zacks Rank #1 (Strong Buy). One stock in the Zacks Domestic Auto space having a Zacks Rank #2 (Buy) is Fox Factory Holding (FOXF).

You can see the complete list of today’s Zacks #1 Rank stocks here.

Fox Factory Holding: The Zacks Consensus Estimate for current-year earnings of this Braselton, GA-based company has remained unchanged at $2.60 over the past 30 days.

Price and Consensus: FOXF


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tesla, Inc. (TSLA): Free Stock Analysis Report
Harley-Davidson, Inc. (HOG): Free Stock Analysis Report
General Motors Company (GM): Free Stock Analysis Report
Fox Factory Holding Corp. (FOXF): Free Stock Analysis Report
Ford Motor Company (F): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.